Cramer’s SELL BLOCK (FEB 1, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Cramer tonight had a quick SELL BLOCK feature where he reviewed names he has previously liked and usually suggests taking your profits.

He has been behind Boston Scientific (BSX-NYSE) for some time thinking the negative cloud swirling was too much.  He said buy at $16+ but now he said you can sell it now and need to sell it now.  Cramer is hearing another stent rumor about problems that he thinks if are true will cause a real negative PR campaign against stents for some time, so he said take the 11% profit on his call and walk away.

Gilead (GILD-NASDAQ) is one he says is NOT on the SELL BLOCK after it rose 11% today and he thinks estimates are too low. He said you can sell a smal bit of it to be safe but hold most of it.

Laureate (LAUR-NASDAQ) is on he said by 14 months ago even though he hates the group.  He thinks it is time to sell into the LBO/MBO now.  He doesn’t want to be in the ARBITRAGE TRADE and it could have downside if the deal is not approved.

Cramer said 3M (MMM-NYSE) is PERMANENTLY on the SELL BLOCK.  They are unpredictable and he said he made a mistake getting behind it.  He’s throwing in the towel on it and management is in the way.  He thinks this one is a bad DJIA stock that you can own better DJIA compoents; even if the next quarter is better it doesn’t mean the company is OK.

Smith & Wesson (SWHC-NASDAQ) is one where he is glad he maintained the sell stance.

Jon C. Ogg
February 1, 2007

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618